NEW YORK, March 18, 2026 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (OVID) (Nasdaq: OVID), a biopharmaceutical company developing small molecule medicines for brain disorders with significant unmet ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results